Submitted Written Public Testimony
| Title | Submitter | On Behalf of | Position | City or Organization | Meeting | Committee |
|---|---|---|---|---|---|---|
| Testimony | Terri Domenigoni | Support | Milwaukie | 3/22/2021 | Senate Committee On Health Care | |
| Letter | Jess Ward | Oppose | National Tax Payers Union | 3/22/2021 | Senate Committee On Health Care | |
| Testimony | Asher Lisec | Deputy VP Public Policy PhRMA | Oppose | Deputy VP Public Policy PhRMA | 3/22/2021 | Senate Committee On Health Care |
| Testimony | Andrew York | Neutral | Maryland Prescription Drug Affordability Board | 3/22/2021 | Senate Committee On Health Care | |
| Testimony | Leah Lindahl | Unknown | Healthcare Distribution Alliance | 3/22/2021 | Senate Committee On Health Care | |
| Letter | Richard Blackwell | PacificSource | Unknown | PacificSource | 3/22/2021 | Senate Committee On Health Care |
| Letter | Mick Gillete | on behalf of PhRMA | Oppose | on behalf of PhRMA | 3/22/2021 | Senate Committee On Health Care |
| Testimony | Bud Pierce | Salem Oncology Specialists | Oppose | Salem Oncology Specialists | 3/22/2021 | Senate Committee On Health Care |
| Testimony | Jane Horvath | Support | Horvath Health Policy | 3/22/2021 | Senate Committee On Health Care | |
| Testimony | Cameron Locklear | Unknown | Newport | 3/22/2021 | Senate Committee On Health Care | |
| Testimony | Maribeth Guarino | Support | Oregon State Public Interest Research Group | 3/22/2021 | Senate Committee On Health Care | |
| Letter | Brian Warren | Oppose | Biotechnology Innovation Organization | 3/22/2021 | Senate Committee On Health Care | |
| Letter | John Mullin | Support | Oregon Coalition for Affordable Prescriptions | 3/22/2021 | Senate Committee On Health Care | |
| Testimony | Andrea Meyer | Support | AARP | 3/22/2021 | Senate Committee On Health Care | |
| Testimony | Bob Estabrook | Oregon School Employees Association | Support | Oregon School Employees Association | 3/22/2021 | Senate Committee On Health Care |
| Testimony | John Mohlis | PILMA | Oppose | Clackamas County | 3/22/2021 | Senate Committee On Health Care |
| Testimony | Dr David Coutin | Oppose | Bend Oregon | 3/22/2021 | Senate Committee On Health Care | |
| Testimony | Jared Mason-Gere | Oregon Education Association | Support | Oregon Education Association | 3/22/2021 | Senate Committee On Health Care |
| Testimony | Tom Sincic | Health Care for All Oregon | Unknown | Health Care for All Oregon | 3/22/2021 | Senate Committee On Health Care |
| Testimony | Tom Sincic | Health Care for All Oregon | Support | Health Care for All Oregon | 3/22/2021 | Senate Committee On Health Care |
| Testimony | Travis Maloney | Oppose | Carver | 3/22/2021 | Senate Committee On Health Care | |
| Testimony | David Wall | Oppose | Newberg | 3/22/2021 | Senate Committee On Health Care | |
| Letter | Marcia Horn | International Cancer Advocacy Network | Neutral | International Cancer Advocacy Network | 3/22/2021 | Senate Committee On Health Care |
| Letter | Mick Gillette | on behalf of PhRMA | Oppose | on behalf of PhRMA | 3/24/2021 | Senate Committee On Health Care |
| Testimony | Bill Cross | Oregon Pharmacy Coalition | Oppose | Silverton | 3/24/2021 | Senate Committee On Health Care |
| Testimony | Katie Shriver | SEIU Oregon State Council | Support | SEIU Oregon State Council | 3/24/2021 | Senate Committee On Health Care |
| Testimony | Charles Gallia | Support | Oregon City | 3/24/2021 | Senate Committee On Health Care | |
| Testimony | Charles Gallia | Support | Oregon City | 3/24/2021 | Senate Committee On Health Care | |
| Testimony | Dr John Choppala | AARP | Support | salem | 3/24/2021 | Senate Committee On Health Care |
| Testimony | Asher Lisec | Deputy VP Policy PhRMA | Oppose | Deputy VP Policy PhRMA | 3/24/2021 | Senate Committee On Health Care |
Presentations Displayed in Committee
No items to display.
Floor Letters
No items to display.
Disclaimer
- The views and opinions expressed in the Public Testimony submitted are those of the submitter and do not reflect the official policy or position of the Oregon Legislature.
- Identifying information provided by the submitter on the Submit Public Testimony form determines the submission title and the submitter associated with the testimony/input file in OLIS. The Oregon Legislature makes no claims that information entered on this form is valid or accurate.
- Input submitted through the Oregon Legislature’s Submit Public Testimony System is run through an initial virus and malware scan. If a possible virus or malware is detected, the file is deleted and not uploaded to OLIS. The Oregon Legislature makes no claims that public input files in OLIS are virus or malware free. We therefore recommend that prior to opening files in OLIS, you ensure the security software on your computer is up to date.
Oregon Legislative Assembly - Public Testimony Registration Form
You are registering to speak about:
SB 844
- Submit the form below to testify or comment either in person or remotely by video or phone. After completing the required fields (*), click the “Submit Registration to Testify” button.
- Email address and phone number are required for administrative purposes and will not be posted to OLIS. Your phone number will be displayed on the livestream of the committee meeting if you testify by phone.
- Registration ends 30 minutes prior to the start of the meeting. After that time, the registration system will close.
- After registering and seeing a confirmation screen, you will receive an email with meeting details. If you do not receive a confirmation email, check your email spam folder.
- Registration does not guarantee that you will have an opportunity to speak; the chair may determine that time for public testimony will be limited. Committee meetings are sometimes cancelled or rescheduled. You can receive email updates on selected bills or committee agendas by signing up for Capitol e-Subscribe.
- If you would like to provide written testimony to the committee, see instructions to submit written testimony here.
- To request spoken language interpretation, American Sign Language (ASL) interpretation, or Communication Access Realtime Translation (CART) services, please email languageaccess@oregonlegislature.gov or call 503-986-1538 at least 3 days in advance.
- Para solicitar servicios de interpretación de lenguaje hablado, interpretación de lenguaje de señas americano (ASL) o traducción en tiempo real de acceso a la comunicación (CART), envíe un correo electrónico a languageaccess@oregonlegislature.gov o llame al 503-986-1538 con 3 dias de anticipación.
You Have Successfully Registered to Testify
Testimony Details:
You will receive an email soon with meeting details. If you registered to testify remotely, the email will include a link or phone number to join the committee meeting.
If you do not receive a confirmation within 24 hours, have any questions, or need to cancel your registration, please call 1-833-588-4500 or email the committee assistant listed on the committee page on OLIS.
Committee meetings are sometimes canceled or rescheduled. If you register to testify and the meeting is rescheduled, you will need to register for the new meeting date. To receive email updates on selected bills or committee agendas, sign up for Capitol E-Subscribe.
Measure Not Scheduled for Public Testimony
Thank you for your interest in providing public testimony on measure .
Either this measure is not currently scheduled for a public hearing, or the deadline to register to testify or to submit written testimony has passed.
For questions about the legislature, legislative process, or other government agencies, please email help.leg@oregonlegislature.gov or call 1-800-332-2313.
Measure Not Scheduled for Public Testimony
Thank you for your interest in providing written testimony on measure .
Either this measure is not currently scheduled for a public hearing, or the deadline to register to testify or to submit written testimony has passed.
For questions about the legislature, legislative process, or other government agencies, please email help.leg@oregonlegislature.gov or call 1-800-332-2313.